v3.26.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Federal grants $ 1,164,315 $ 1,371,438 $ 2,125,313 $ 2,691,210
Operating expenses:        
Research and development 2,471,752 1,923,430 5,818,633 3,808,957
General and administrative 1,268,952 1,198,523 2,445,299 2,600,279
Total operating expenses 3,740,704 3,121,953 8,263,932 6,409,236
Loss from operations (2,576,389) (1,750,515) (6,138,619) (3,718,026)
Other income (expense):        
Change in fair value of liability classified warrants (853) 9,063
Interest expense, net (320) (3,160) (4,243) (7,017)
Other income and expense, net 5,834 21,011 15,572 36,890
Total other income (expense), net 5,514 16,998 11,329 38,936
Net loss (2,570,875) (1,733,517) (6,127,290) (3,679,090)
Net loss attributable to noncontrolling interests (166) (166) (166) (166)
Deemed dividend related to warrants down round provision
Net loss attributable to common stockholders $ (2,570,709) $ (1,733,351) $ (6,127,124) $ (3,678,924)
Net loss per basic and diluted share:        
Net loss per share attributable to common stockholders, basic $ (0.20) $ (0.79) $ (0.62) $ (2.04)
Net loss per share attributable to common stockholders, diluted $ (0.20) $ (0.79) $ (0.62) $ (2.04)
Weighted average common shares outstanding, basic 13,035,632 2,202,299 9,954,626 1,803,393
Weighted average common shares outstanding, diluted 13,035,632 2,202,299 9,954,626 1,803,393